| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Storr Liver Unit, Departments of Clinical Pharmacology (C.L., B.J.G.) and Medicine (J.G., M.T., G.C.F.), University of Sydney at Westmead Hospital, Westmead 2145, Australia
Address all correspondence and requests for reprints to: Dr. C. Liddle, Department of Clinical Pharmacology, Westmead Hospital, Westmead 2145, Australia. E-mail: chrisl{at}westgate.wh.usyd.edu.au
CYP3A4, the predominant cytochrome P450 expressed in human liver, is responsible for the metabolism of endogenous steroids and many drugs. On the basis of pharmacokinetic studies in patients with hormonal derangements and the effects of replacement therapy, it has been suggested that iodothyronines decrease CYP3A4-mediated drug metabolism, whereas glucocorticoids and GH enhance CYP3A4 activity. The aim of the present study, using well differentiated human hepatocytes in primary culture, was to examine directly whether hormonal factors regulate CYP3A4 gene expression. Addition of T3 to primary hepatocytes resulted in a marked reduction of CYP3A4-catalyzed testosterone 6ß-hydroxylase activity and corresponding levels of CYP3A4 protein and messenger ribonucleic acid compared to those in untreated cells. Conversely, both dexamethasone and GH treatment substantially increased CYP3A4 gene expression. None of the hormones studied consistently altered the expression of other human cytochrome P450 genes. We conclude that iodothyronines, glucocorticoids, and GH act directly on human hepatocytes to regulate the expression of CYP3A4, and these effects appear to be exerted at a pretranslational level. Altered regulation of hepatic CYP3A4 is, therefore, likely to account for previous observations concerning the effects of endocrine diseases and hormonal treatments on human cytochrome P450-mediated drug and steroid metabolism.
This article has been cited by other articles:
![]() |
D. J. Waxman and M. G. Holloway Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes Mol. Pharmacol., August 1, 2009; 76(2): 215 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Debono, R. J Ross, and J. Newell-Price Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy Eur. J. Endocrinol., May 1, 2009; 160(5): 719 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, X. Wu, H. Wang, A. M. Mikheev, Q. Mao, and J. D. Unadkat Effect of Pregnancy on Cytochrome P450 3a and P-Glycoprotein Expression and Activity in the Mouse: Mechanisms, Tissue Specificity, and Time Course Mol. Pharmacol., September 1, 2008; 74(3): 714 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sakuma, W. Bhadhprasit, T. Hashita, and N. Nemoto Synergism of Glucocorticoid Hormone with Growth Hormone for Female-Specific Mouse Cyp3a44 Gene Expression Drug Metab. Dispos., May 1, 2008; 36(5): 878 - 884. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Waxman and C. O'Connor Growth Hormone Regulation of Sex-Dependent Liver Gene Expression Mol. Endocrinol., November 1, 2006; 20(11): 2613 - 2629. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cheung, A.-M. Yu, C.-S. Chen, K. W. Krausz, L. G. Byrd, L. Feigenbaum, R. J. Edwards, D. J. Waxman, and F. J. Gonzalez Growth Hormone Determines Sexual Dimorphism of Hepatic Cytochrome P450 3A4 Expression in Transgenic Mice J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1328 - 1334. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Dhir, W. Dworakowski, C. Thangavel, and B. H. Shapiro Sexually Dimorphic Regulation of Hepatic Isoforms of Human Cytochrome P450 by Growth Hormone J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 87 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hecker, J.-W. Park, M. B. Murphy, P. D. Jones, K. R. Solomon, G. Van Der Kraak, J. A. Carr, E. E. Smith, L. du Preez, R. J. Kendall, et al. Effects of Atrazine on CYP19 Gene Expression and Aromatase Activity in Testes and on Plasma Sex Steroid Concentrations of Male African Clawed Frogs (Xenopus laevis) Toxicol. Sci., August 1, 2005; 86(2): 273 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Yu, K. Fukamachi, K. W. Krausz, C. Cheung, and F. J. Gonzalez Potential Role for Human Cytochrome P450 3A4 in Estradiol Homeostasis Endocrinology, July 1, 2005; 146(7): 2911 - 2919. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Eleswarapu and H Jiang Growth hormone regulates the expression of hepatocyte nuclear factor-3 gamma and other liver-enriched transcription factors in the bovine liver J. Endocrinol., January 1, 2005; 184(1): 95 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, M. Nie, J. Sham, C. Su, H. Xue, D. Chua, W. Wang, Z. Cui, Y. Liu, C. Liu, et al. Effective Gene-Viral Therapy for Telomerase-Positive Cancers by Selective Replicative-Competent Adenovirus Combining with Endostatin Gene Cancer Res., August 1, 2004; 64(15): 5390 - 5397. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Dhir and B. H. Shapiro Interpulse growth hormone secretion in the episodic plasma profile causes the sex reversal of cytochrome P450s in senescent male rats PNAS, December 9, 2003; 100(25): 15224 - 15228. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Stevens, R. N. Hines, C. Gu, S. B. Koukouritaki, J. R. Manro, P. J. Tandler, and M. J. Zaya Developmental Expression of the Major Human Hepatic CYP3A Enzymes J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 573 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Robertson, J. Field, B. Goodwin, S. Bierach, M. Tran, A. Lehnert, and C. Liddle Transgenic Mouse Models of Human CYP3A4 Gene Regulation Mol. Pharmacol., July 1, 2003; 64(1): 42 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Jaffe, D. K. Turgeon, K. Lown, R. Demott-Friberg, and P. B. Watkins Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E1008 - E1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Kliewer, B. Goodwin, and T. M. Willson The Nuclear Pregnane X Receptor: A Key Regulator of Xenobiotic Metabolism Endocr. Rev., October 1, 2002; 23(5): 687 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Goodwin, E. Hodgson, and C. Liddle The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module Mol. Pharmacol., December 1, 1999; 56(6): 1329 - 1339. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |